UBS Group Boosts Keurig Dr Pepper (NASDAQ:KDP) Price Target to $42.00

Keurig Dr Pepper (NASDAQ:KDP) had its price objective hoisted by UBS Group from $40.00 to $42.00 in a research report sent to investors on Thursday morning,Benzinga reports. They currently have a buy rating on the stock.

Several other equities research analysts also recently weighed in on the stock. Barclays set a $39.00 target price on shares of Keurig Dr Pepper in a research note on Thursday, February 27th. Piper Sandler upgraded Keurig Dr Pepper from a “neutral” rating to an “overweight” rating and lifted their target price for the company from $35.00 to $40.00 in a research note on Wednesday, April 9th. Morgan Stanley upgraded Keurig Dr Pepper from an “equal weight” rating to an “overweight” rating and upped their price target for the stock from $38.00 to $40.00 in a research note on Tuesday, April 1st. Wells Fargo & Company reiterated an “overweight” rating on shares of Keurig Dr Pepper in a research report on Tuesday, February 25th. Finally, Argus began coverage on shares of Keurig Dr Pepper in a research report on Wednesday. They set a “buy” rating and a $40.00 price objective for the company. Four equities research analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $39.21.

Keurig Dr Pepper Trading Up 0.9 %

KDP opened at $35.41 on Thursday. The firm has a market cap of $48.04 billion, a price-to-earnings ratio of 21.46, a price-to-earnings-growth ratio of 2.42 and a beta of 0.54. Keurig Dr Pepper has a 52 week low of $30.12 and a 52 week high of $38.28. The business’s 50 day moving average is $33.74 and its two-hundred day moving average is $33.29. The company has a quick ratio of 0.36, a current ratio of 0.53 and a debt-to-equity ratio of 0.50.

Keurig Dr Pepper (NASDAQ:KDP) last announced its earnings results on Tuesday, February 25th. The company reported $0.58 EPS for the quarter, beating analysts’ consensus estimates of $0.57 by $0.01. The business had revenue of $4.07 billion for the quarter, compared to analysts’ expectations of $4.01 billion. Keurig Dr Pepper had a net margin of 15.04% and a return on equity of 10.45%. The company’s quarterly revenue was up 5.2% on a year-over-year basis. During the same period in the previous year, the company posted $0.55 EPS. On average, research analysts predict that Keurig Dr Pepper will post 1.92 EPS for the current year.

Keurig Dr Pepper Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were given a dividend of $0.23 per share. The ex-dividend date was Friday, March 28th. This represents a $0.92 dividend on an annualized basis and a dividend yield of 2.60%. Keurig Dr Pepper’s payout ratio is 87.62%.

Insider Buying and Selling

In other Keurig Dr Pepper news, major shareholder Bevco B.V. Jab sold 83,950,000 shares of the company’s stock in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $32.65, for a total value of $2,740,967,500.00. Following the sale, the insider now owns 134,113,479 shares of the company’s stock, valued at $4,378,805,089.35. This represents a 38.50 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Chairman Robert James Gamgort sold 416,000 shares of the stock in a transaction that occurred on Tuesday, March 4th. The shares were sold at an average price of $34.29, for a total transaction of $14,264,640.00. Following the completion of the sale, the chairman now owns 3,237,066 shares in the company, valued at $110,998,993.14. This represents a 11.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 84,409,350 shares of company stock worth $2,756,709,930 in the last quarter. Company insiders own 1.00% of the company’s stock.

Institutional Investors Weigh In On Keurig Dr Pepper

Institutional investors and hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. increased its position in Keurig Dr Pepper by 23.6% during the fourth quarter. Vanguard Group Inc. now owns 119,587,162 shares of the company’s stock worth $3,841,140,000 after buying an additional 22,856,757 shares in the last quarter. Wellington Management Group LLP boosted its stake in shares of Keurig Dr Pepper by 10.3% during the fourth quarter. Wellington Management Group LLP now owns 60,602,781 shares of the company’s stock valued at $1,946,561,000 after acquiring an additional 5,646,179 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in Keurig Dr Pepper by 36.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 54,656,384 shares of the company’s stock worth $1,755,564,000 after purchasing an additional 14,473,054 shares in the last quarter. Geode Capital Management LLC raised its stake in Keurig Dr Pepper by 8.7% in the 4th quarter. Geode Capital Management LLC now owns 24,511,039 shares of the company’s stock valued at $784,974,000 after purchasing an additional 1,962,195 shares during the last quarter. Finally, Invesco Ltd. lifted its holdings in Keurig Dr Pepper by 19.6% in the 4th quarter. Invesco Ltd. now owns 21,605,610 shares of the company’s stock valued at $693,972,000 after purchasing an additional 3,539,463 shares in the last quarter. Hedge funds and other institutional investors own 93.99% of the company’s stock.

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.